Browsing Research publications by Author "Gue, Ying X"
Now showing items 1-1 of 1
-
Rationale and design of "Can Very Low Dose Rivaroxaban (VLDR) in addition to dual antiplatelet therapy improve thrombotic status in acute coronary syndrome (VaLiDate-R)" study : A randomised trial modulating endogenous fibrinolysis in patients with acute coronary syndrome
Gue, Ying X; Kanji, Rahim; Wellsted, David M; Srinivasan, Manivannan; Wyatt, Solange; Gorog, Diana A (2019-12-23)Impaired endogenous fibrinolysis is novel biomarker that can identify patients with ACS at increased cardiovascular risk. The addition of Very Low Dose Rivaroxaban (VLDR) to dual antiplatelet therapy has been shown to ...